Global Information
회사소개 | 문의 | 위시리스트

신장 결석 관리 시장 : 산업 분석, 지역별 전망, 응용 가능성, 경쟁 시장 점유율, 예측

Kidney Stones Management Market Size By Technology Size By Type, By Diagnostics, By Treatment, Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2018 - 2024

리서치사 Global Market Insights Inc.
발행일 2018년 12월 상품 코드 648650
페이지 정보 영문 150 Pages
가격
US $ 5,150 ₩ 6,153,000 Unprintable PDF (Single User License)
US $ 7,150 ₩ 8,543,000 Printable PDF (Multi User License)
US $ 9,150 ₩ 10,933,000 Printable PDF (Enterprise User License)


신장 결석 관리 시장 : 산업 분석, 지역별 전망, 응용 가능성, 경쟁 시장 점유율, 예측 Kidney Stones Management Market Size By Technology Size By Type, By Diagnostics, By Treatment, Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2018 - 2024
발행일 : 2018년 12월 페이지 정보 : 영문 150 Pages

세계의 신장 결석 관리 시장에 대해 조사분석했으며, 산업 인사이트, 부문별 시장 분석, 지역별 분석, 주요 기업 등의 정보를 정리하여 전해드립니다.

제1장 조사 방법

제2장 개요

제3장 신장 결석 관리 산업 인사이트

  • 산업 세분화
  • 산업 상황
  • 산업 에코시스템
  • 유통경로 분석
  • 산업 영향력
  • 성장 가능성 분석
  • 규제 상황
  • Porter의 산업 분석
  • 기업 상황
  • PESTEL 분석

제4장 신장 결석 관리 시장 : 종류별

  • 주요 부문 동향
  • 옥살산칼슘
  • 인산칼슘
  • 요산
  • 스트루바이트
  • 시스테인

제5장 신장 결석 관리 시장 : 진단별

  • 주요 부문 동향
  • 복부 X선
  • CT 스캔
  • 초음파
  • 복부 MRI
  • IVP
  • 기타

제6장 신장 결석 관리 시장 : 치료별

  • 주요 부문 동향
  • 체외 충격파 쇄석술(ESWL/SWL)
  • 레이저 쇄석/요도경
  • 경피적 신쇄석술(PNL)
  • 기타

제7장 신장 결석 관리 시장 : 지역별

  • 주요 부문 동향
  • 북미
  • 유럽
  • 아시아태평양
  • 라틴아메리카
  • 중동·아프리카

제8장 기업 개요

  • Allengers Medical Systems Ltd.
  • Boston Scientific Corporation
  • C.R. Bard, Inc.
  • Karl Storz GmbH & Co. KG
  • Cook Medical
  • Coloplast Group
  • DirexGroup
  • Dornier MedTech
  • Olympus Corporation
  • Richard Wolf GmbH
  • EDAP TMS SA
  • Elmed Medical Systems
  • Siemens Healthcare
  • Medispec Ltd.
KSA 18.06.19

이 페이지에 게재되어 있는 내용은 최신판과 약간 차이가 있을 수 있으므로 영문목차를 함께 참조하여 주시기 바랍니다. 기타 자세한 사항은 문의 바랍니다.

Data Tables

  • TABLE 1. Kidney stones management industry 360 degree synopsis, 2013 - 2024
  • TABLE 2. Global kidney stones management market, 2013 - 2024 (USD Million)
  • TABLE 3. Global kidney stones management market, by type, 2013 - 2024 (USD Million)
  • TABLE 4. Global kidney stones management market, by diagnostics, 2013 - 2024 (USD Million)
  • TABLE 5. Global kidney stones management market, by treatment, 2013 - 2024 (USD Million)
  • TABLE 6. Global kidney stones management market, by region, 2013 - 2024 (USD Million)
  • TABLE 7. Industry impact forces
  • TABLE 8. Calcium oxalate market size, by region, 2013 - 2024 (USD Million)
  • TABLE 9. Calcium phosphate market size, by region, 2013 - 2024 (USD Million)
  • TABLE 10. Uric acid market size, by region, 2013 - 2024 (USD Million)
  • TABLE 11. Struvite market size, by region, 2013 - 2024 (USD Million)
  • TABLE 12. Cysteine market size, by region, 2013 - 2024 (USD Million)
  • TABLE 13. Abdominal X-ray market size, by region, 2013 - 2024 (USD Million)
  • TABLE 14. Computed tomography market size, by region, 2013 - 2024 (USD Million)
  • TABLE 15. Ultrasound market size, by region, 2013 - 2024 (USD Million)
  • TABLE 16. Abdominal MRI market size, by region, 2013 - 2024 (USD Million)
  • TABLE 17. Intravenous pyelography market size, by region, 2013 - 2024 (USD Million)
  • TABLE 18. Others market size, by region, 2013 - 2024 (USD Million)
  • TABLE 19. ESWL market size, by region, 2013 - 2024 (USD Million)
  • TABLE 20. Ureteroscopy market size, by region, 2013 - 2024 (USD Million)
  • TABLE 21. PCNL market size, by region, 2013 - 2024 (USD Million)
  • TABLE 22. Others market size, by region, 2013 - 2024 (USD Million)
  • TABLE 23. North America kidney stones management market size, by country, 2013 - 2024 (USD Million)
  • TABLE 24. North America kidney stones management market size, by type, 2013 - 2024 (USD Million)
  • TABLE 25. North America kidney stones management market size, by diagnostics, 2013 - 2024 (USD Million)
  • TABLE 26. North America kidney stones management market size, by treatment, 2013 - 2024 (USD Million)
  • TABLE 27. U.S. kidney stones management market size, by type, 2013 - 2024 (USD Million)
  • TABLE 28. U.S. kidney stones management market size, by diagnostics, 2013 - 2024 (USD Million)
  • TABLE 29. U.S. kidney stones management market size, by treatment, 2013 - 2024 (USD Million)
  • TABLE 30. Canada kidney stones management market size, by type, 2013 - 2024 (USD Million)
  • TABLE 31. Canada kidney stones management market size, by diagnostics, 2013 - 2024 (USD Million)
  • TABLE 32. Canada kidney stones management market size, by treatment, 2013 - 2024 (USD Million)
  • TABLE 33. Europe kidney stones management market size, by country, 2013 - 2024 (USD Million)
  • TABLE 34. Europe kidney stones management market size, by type, 2013 - 2024 (USD Million)
  • TABLE 35. Europe kidney stones management market size, by diagnostics, 2013 - 2024 (USD Million)
  • TABLE 36. Europe kidney stones management market size, by treatment, 2013 - 2024 (USD Million)
  • TABLE 37. Germany kidney stones management market size, by type, 2013 - 2024 (USD Million)
  • TABLE 38. Germany kidney stones management market size, by diagnostics, 2013 - 2024 (USD Million)
  • TABLE 39. Germany kidney stones management market size, by treatment, 2013 - 2024 (USD Million)
  • TABLE 40. UK kidney stones management market size, by type, 2013 - 2024 (USD Million)
  • TABLE 41. UK kidney stones management market size, by diagnostics, 2013 - 2024 (USD Million)
  • TABLE 42. UK kidney stones management market size, by treatment, 2013 - 2024 (USD Million)
  • TABLE 43. France kidney stones management market size, by type, 2013 - 2024 (USD Million)
  • TABLE 44. France kidney stones management market size, by diagnostics, 2013 - 2024 (USD Million)
  • TABLE 45. France kidney stones management market size, by treatment, 2013 - 2024 (USD Million)
  • TABLE 46. Italy kidney stones management market size, by type, 2013 - 2024 (USD Million)
  • TABLE 47. Italy kidney stones management market size, by diagnostics, 2013 - 2024 (USD Million)
  • TABLE 48. Italy kidney stones management market size, by treatment, 2013 - 2024 (USD Million)
  • TABLE 49. Spain kidney stones management market size, by type, 2013 - 2024 (USD Million)
  • TABLE 50. Spain kidney stones management market size, by diagnostics, 2013 - 2024 (USD Million)
  • TABLE 51. Spain kidney stones management market size, by treatment, 2013 - 2024 (USD Million)
  • TABLE 52. Russia kidney stones management market size, by type, 2013 - 2024 (USD Million)
  • TABLE 53. Russia kidney stones management market size, by diagnostics, 2013 - 2024 (USD Million)
  • TABLE 54. Russia kidney stones management market size, by treatment, 2013 - 2024 (USD Million)
  • TABLE 55. APAC kidney stones management market size, by country, 2013 - 2024 (USD Million)
  • TABLE 56. APAC kidney stones management market size, by type, 2013 - 2024 (USD Million)
  • TABLE 57. APAC kidney stones management market size, by diagnostics, 2013 - 2024 (USD Million)
  • TABLE 58. APAC kidney stones management market size, by treatment, 2013 - 2024 (USD Million)
  • TABLE 59. Japan kidney stones management market size, by type, 2013 - 2024 (USD Million)
  • TABLE 60. Japan kidney stones management market size, by diagnostics, 2013 - 2024 (USD Million)
  • TABLE 61. Japan kidney stones management market size, by treatment, 2013 - 2024 (USD Million)
  • TABLE 62. China kidney stones management market size, by type, 2013 - 2024 (USD Million)
  • TABLE 63. China kidney stones management market size, by diagnostics, 2013 - 2024 (USD Million)
  • TABLE 64. China kidney stones management market size, by treatment, 2013 - 2024 (USD Million)
  • TABLE 65. India kidney stones management market size, by type, 2013 - 2024 (USD Million)
  • TABLE 66. India kidney stones management market size, by diagnostics, 2013 - 2024 (USD Million)
  • TABLE 67. India kidney stones management market size, by treatment, 2013 - 2024 (USD Million)
  • TABLE 68. South Korea kidney stones management market size, by type, 2013 - 2024 (USD Million)
  • TABLE 69. South Korea kidney stones management market size, by diagnostics, 2013 - 2024 (USD Million)
  • TABLE 70. South Korea kidney stones management market size, by treatment, 2013 - 2024 (USD Million)
  • TABLE 71. LATAM kidney stones management market size, by country, 2013 - 2024 (USD Million)
  • TABLE 72. LATAM kidney stones management market size, by type, 2013 - 2024 (USD Million)
  • TABLE 73. LATAM kidney stones management market size, by diagnostics, 2013 - 2024 (USD Million)
  • TABLE 74. LATAM kidney stones management market size, by treatment, 2013 - 2024 (USD Million)
  • TABLE 75. Brazil kidney stones management market size, by type, 2013 - 2024 (USD Million)
  • TABLE 76. Brazil kidney stones management market size, by diagnostics, 2013 - 2024 (USD Million)
  • TABLE 77. Brazil kidney stones management market size, by treatment, 2013 - 2024 (USD Million)
  • TABLE 78. Mexico kidney stones management market size, by type, 2013 - 2024 (USD Million)
  • TABLE 79. Mexico kidney stones management market size, by diagnostics, 2013 - 2024 (USD Million)
  • TABLE 80. Mexico kidney stones management market size, by treatment, 2013 - 2024 (USD Million)
  • TABLE 81. Argentina kidney stones management market size, by type, 2013 - 2024 (USD Million)
  • TABLE 82. Argentina kidney stones management market size, by diagnostics, 2013 - 2024 (USD Million)
  • TABLE 83. Argentina kidney stones management market size, by treatment, 2013 - 2024 (USD Million)
  • TABLE 84. MEA kidney stones management market size, by country, 2013 - 2024 (USD Million)
  • TABLE 85. MEA kidney stones management market size, by type, 2013 - 2024 (USD Million)
  • TABLE 86. MEA kidney stones management market size, by diagnostics, 2013 - 2024 (USD Million)
  • TABLE 87. MEA kidney stones management market size, by treatment, 2013 - 2024 (USD Million)
  • TABLE 88. South Africa kidney stones management market size, by type, 2013 - 2024 (USD Million)
  • TABLE 89. South Africa kidney stones management market size, by diagnostics, 2013 - 2024 (USD Million)
  • TABLE 90. South Africa kidney stones management market size, by treatment, 2013 - 2024 (USD Million)
  • TABLE 91. Saudi Arabia kidney stones management market size, by type, 2013 - 2024 (USD Million)
  • TABLE 92. Saudi Arabia kidney stones management market size, by diagnostics, 2013 - 2024 (USD Million)
  • TABLE 93. Saudi Arabia kidney stones management market size, by treatment, 2013 - 2024 (USD Million)
  • TABLE 94. UAE kidney stones management market size, by type, 2013 - 2024 (USD Million)
  • TABLE 95. UAE kidney stones management market size, by diagnostics, 2013 - 2024 (USD Million)
  • TABLE 96. UAE kidney stones management market size, by treatment, 2013 - 2024 (USD Million)

Charts & Figures

  • FIG 1. Industry segmentation
  • FIG 2. Global kidney stones management market, 2013 - 2024 (USD Million)
  • FIG 3. Industry ecosystem
  • FIG 4. Distribution channel analysis
  • FIG 5. Growth potential analysis, by type
  • FIG 6. Growth potential analysis, by diagnostics
  • FIG 7. Growth potential analysis, by treatment
  • FIG 8. Porter's analysis
  • FIG 9. Strategic dashboard
  • FIG 10. PESTEL analysis

Title:
Kidney Stones Management Market Size By Technology Size By Type (Calcium Oxalate, Calcium Phosphate, Uric Acid, Struvite, Cysteine), By Diagnostics (Abdominal X-ray, Computed Tomography Scan, Ultrasound, Abdominal MRI, Intravenous Pyelography), By Treatment (Extracorporeal Shock Wave Lithotripsy, Ureteroscopy, Percutaneous Nephrolithotomy), Industry Analysis Report, Regional Outlook (U.S., Canada, UK, Germany, France, Italy, Spain, Russia, China, Japan, India, South Korea, Brazil, Mexico, Argentina, South Africa, Saudi Arabia, UAE), Application Potential, Competitive Market Share & Forecast, 2018 - 2024.

Kidney stones management market will exceed USD 2.0 billion by 2024; as per a new research report.

Increasing prevalence and relapse rate of kidney stones are major impact rendering factors for kidney stones management industry growth. In addition, the technological advancements in the field of Extracorporeal shock wave lithotripsy (ESWL) and ureteroscopy also augment industry growth. Moreover, rising acute diagnostic techniques such as imaging techniques like CT scan that will foster kidney stones management market in upcoming years.

Rising patient preference towards development of minimally invasive surgeries for kidney stone diseases is one of the contributing factors for kidney stones management business growth. In addition, increasing awareness regarding overall kidney health will augment kidney stones management business growth in forthcoming years. For instance, National Kidney Foundation promotes Medicare, Medicaid and health plans. These awareness programs help in encouraging primary care practitioners to improve earlier detection, and management of kidney diseases thereby augmenting business growth. However, potential long-term adverse effects of lithotripsy will hinder the kidney stones management industry growth.

Calcium oxalate segment was valued at USD 1.2 billion in 2017 and is projected to grow significantly over the forecast timeframe. The growth is attributable to increasing consumption of more amount of oxalate rich food and less intake of fluids leading to stone formation thereby propelling industry growth.

Ultrasound segment will witness 23.4% revenue share in 2017 due to growing prevalence of kidney stone diseases. Moreover, widespread adoption ultrasound technology as a gold standard for diagnosing kidney stones will accelerate the segmental growth in forthcoming years.

Ureteroscopy segment will grow at a 5.5% owing to the technological advancements in ureteroscopes including smaller and flexible ureteroscopes and advanced higher definition cameras. Such rising technological advancements should drive the business growth.

U.S. kidney stones management industry is anticipated to show significant industry growth during the forecast timeframe owing to rising prevalence of kidney stones in the country as well as increasing adoption of minimally invasive surgical procedures. According to National Institute of Diabetes and Digestive and Kidney Diseases, more than 1 million kidney stone cases observed every year in the U.S. Moreover, U.S. witnesses high screening and diagnosis rate due to increased awareness regarding kidney diseases thereby rendering positive impact on kidney stones management industry.

China kidney stones management market was valued at USD 75.2 million in 2017 and is estimated to experience considerable growth over the coming years owing to rising unmet medical needs coupled with rapidly growing aging population. As per Research Gate Scientific report 2017, the prevalence of kidney stones disease in China was 7.54% in 2017. Rising prevalence of kidney stone diseases ultimately increases the adoption of advanced kidney stones management devices thereby propelling business growth.

Some of the prominent competitors operating in kidney stones management market include: Allengers Medical Systems, Boston Scientific Corporation, C.R. Bard, Karl Storz GmbH & Co. KG, Cook Medical, Coloplast Group, Olympus Corporation. Industry competitors are mainly focusing on inorganic strategies such as partnership, merger and acquisitions. These inorganic strategies help in strengthening company's foothold in kidney stones management market.

Table of Contents

Chapter 1. Methodology

  • 1.1. Methodology
  • 1.2. Market definitions
  • 1.3. Forecast parameters
  • 1.4. Data sources
    • 1.4.1. Secondary
      • 1.4.1.1. Paid sources
      • 1.4.1.2. Unpaid sources
    • 1.4.2. Primary

Chapter 2. Executive Summary

  • 2.1. Kidney stones industry 360 degree synopsis, 2013 - 2024
    • 2.1.1. Business trends
    • 2.1.2. Type trends
    • 2.1.3. Diagnostics trends
    • 2.1.4. Treatment trends
    • 2.1.5. Regional trends

Chapter 3. Kidney Stones Industry Insights

  • 3.1. Industry segmentation
  • 3.2. Industry landscape, 2013 - 2024
  • 3.3. Industry impact forces
    • 3.3.1. Growth drivers
      • 3.3.1.1. Increasing prevalence and recurrence rate of kidney stones globally
      • 3.3.1.2. Advancements in ureteroscopy technique
      • 3.3.1.3. Favorable reimbursement for lithotripsy procedures
      • 3.3.1.4. Inclination towards undergoing minimally invasive surgeries
      • 3.3.1.5. Rising awareness regarding overall kidney health
    • 3.3.2. Industry pitfalls and challenges
      • 3.3.2.1. Lack of treatment awareness in certain countries
      • 3.3.2.2. Potential long-term adverse effects of lithotripsy
  • 3.4. Regulatory landscape
    • 3.4.1. U.S.
    • 3.4.2. Europe
    • 3.4.3. China
  • 3.5. Growth potential analysis
    • 3.5.1. By type
    • 3.5.2. By diagnostics
    • 3.5.3. By treatment
  • 3.6. Porter's analysis
  • 3.7. Competitive landscape, 2017
    • 3.7.1. Strategy dashboard
  • 3.8. PESTEL analysis

Chapter 4. Kidney Stones Market, By Type

  • 4.1. Key segment trends
  • 4.2. Calcium oxalate
    • 4.2.1. Market size, by region, 2013-2024 (USD Million)
  • 4.3. Calcium phosphate
    • 4.3.1. Market size, by region, 2013-2024 (USD Million)
  • 4.4. Uric acid
    • 4.4.1. Market size, by region, 2013-2024 (USD Million)
  • 4.5. Struvite
    • 4.5.1. Market size, by region, 2013-2024 (USD Million)
  • 4.6. Cysteine
    • 4.6.1. Market size, by region, 2013-2024 (USD Million)

Chapter 5. Kidney Stones Market, By Diagnostics

  • 5.1. Key segment trends
  • 5.2. Abdominal X-ray
    • 5.2.1. Market size, by region, 2013-2024 (USD Million)
  • 5.3. Computed Tomography
    • 5.3.1. Market size, by region, 2013-2024 (USD Million)
  • 5.4. Ultrasound
    • 5.4.1. Market size, by region, 2013-2024 (USD Million)
  • 5.5. Abdominal MRI
    • 5.5.1. Market size, by region, 2013-2024 (USD Million)
  • 5.6. Intravenous Pyelography
    • 5.6.1. Market size, by region, 2013-2024 (USD Million)
  • 5.7. Others
    • 5.7.1. Market size, by region, 2013-2024 (USD Million)

Chapter 6. Kidney Stones Market, By Treatment

  • 6.1. Key segment trends
  • 6.2. Extracorporeal Shock Wave Lithotripsy (ESWL)
    • 6.2.1. Market size, by region, 2013-2024 (USD Million)
  • 6.3. Ureteroscopy
    • 6.3.1. Market size, by region, 2013-2024 (USD Million)
  • 6.4. Percutaneous Nephrolithotomy (PCNL)
    • 6.4.1. Market size, by region, 2013-2024 (USD Million)
  • 6.5. Others
    • 6.5.1. Market size, by region, 2013-2024 (USD Million)

Chapter 7. Kidney Stones Market, By Region

  • 7.1. Key regional trends
  • 7.2. North America
    • 7.2.1. Market size, by country, 2013 - 2024 (USD Million)
    • 7.2.2. Market size, by type, 2013 - 2024 (USD Million)
    • 7.2.3. Market size, by diagnostics, 2013 - 2024 (USD Million)
    • 7.2.4. Market size, by treatment, 2013 - 2024 (USD Million)
    • 7.2.5. U.S.
      • 7.2.5.1. Market size, by type, 2013 - 2024 (USD Million)
      • 7.2.5.2. Market size, by diagnostics, 2013 - 2024 (USD Million)
      • 7.2.5.3. Market size, by treatment, 2013 - 2024 (USD Million)
    • 7.2.6. Canada
      • 7.2.6.1. Market size, by type, 2013 - 2024 (USD Million)
      • 7.2.6.2. Market size, by diagnostics, 2013 - 2024 (USD Million)
      • 7.2.6.3. Market size, by treatment, 2013 - 2024 (USD Million)
  • 7.3. Europe
    • 7.3.1. Market size, by country, 2013 - 2024 (USD Million)
    • 7.3.2. Market size, by type, 2013 - 2024 (USD Million)
    • 7.3.3. Market size, by diagnostics, 2013 - 2024 (USD Million)
    • 7.3.4. Market size, by treatment, 2013 - 2024 (USD Million)
    • 7.3.5. Germany
      • 7.3.5.1. Market size, by type, 2013 - 2024 (USD Million)
      • 7.3.5.2. Market size, by diagnostics, 2013 - 2024 (USD Million)
      • 7.3.5.3. Market size, by treatment, 2013 - 2024 (USD Million)
    • 7.3.6. France
      • 7.3.6.1. Market size, by type, 2013 - 2024 (USD Million)
      • 7.3.6.2. Market size, by diagnostics, 2013 - 2024 (USD Million)
      • 7.3.6.3. Market size, by treatment, 2013 - 2024 (USD Million)
    • 7.3.7. UK
      • 7.3.7.1. Market size, by type, 2013 - 2024 (USD Million)
      • 7.3.7.2. Market size, by diagnostics, 2013 - 2024 (USD Million)
      • 7.3.7.3. Market size, by treatment, 2013 - 2024 (USD Million)
    • 7.3.8. Italy
      • 7.3.8.1. Market size, by type, 2013 - 2024 (USD Million)
      • 7.3.8.2. Market size, by diagnostics, 2013 - 2024 (USD Million)
      • 7.3.8.3. Market size, by treatment, 2013 - 2024 (USD Million)
    • 7.3.9. Spain
      • 7.3.9.1. Market size, by type, 2013 - 2024 (USD Million)
      • 7.3.9.2. Market size, by diagnostics, 2013 - 2024 (USD Million)
      • 7.3.9.3. Market size, by treatment, 2013 - 2024 (USD Million)
    • 7.3.10. Russia
      • 7.3.10.1. Market size, by type, 2013 - 2024 (USD Million)
      • 7.3.10.2. Market size, by diagnostics, 2013 - 2024 (USD Million)
      • 7.3.10.3. Market size, by treatment, 2013 - 2024 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. Market size, by country, 2013 - 2024 (USD Million)
    • 7.4.2. Market size, by type, 2013 - 2024 (USD Million)
    • 7.4.3. Market size, by diagnostics, 2013 - 2024 (USD Million)
    • 7.4.4. Market size, by treatment, 2013 - 2024 (USD Million)
    • 7.4.5. China
      • 7.4.5.1. Market size, by type, 2013 - 2024 (USD Million)
      • 7.4.5.2. Market size, by diagnostics, 2013 - 2024 (USD Million)
      • 7.4.5.3. Market size, by treatment, 2013 - 2024 (USD Million)
    • 7.4.6. Japan
      • 7.4.6.1. Market size, by type, 2013 - 2024 (USD Million)
      • 7.4.6.2. Market size, by diagnostics, 2013 - 2024 (USD Million)
      • 7.4.6.3. Market size, by treatment, 2013 - 2024 (USD Million)
    • 7.4.7. India
      • 7.4.7.1. Market size, by type, 2013 - 2024 (USD Million)
      • 7.4.7.2. Market size, by diagnostics, 2013 - 2024 (USD Million)
      • 7.4.7.3. Market size, by treatment, 2013 - 2024 (USD Million)
    • 7.4.8. South Korea
      • 7.4.8.1. Market size, by type, 2013 - 2024 (USD Million)
      • 7.4.8.2. Market size, by diagnostics, 2013 - 2024 (USD Million)
      • 7.4.8.3. Market size, by treatment, 2013 - 2024 (USD Million)
  • 7.5. Latin America
    • 7.5.1. Market size, by country, 2013 - 2024 (USD Million)
    • 7.5.2. Market size, by type, 2013 - 2024 (USD Million)
    • 7.5.3. Market size, by diagnostics, 2013 - 2024 (USD Million)
    • 7.5.4. Market size, by treatment, 2013 - 2024 (USD Million)
    • 7.5.5. Brazil
      • 7.5.5.1. Market size, by type, 2013 - 2024 (USD Million)
      • 7.5.5.2. Market size, by diagnostics, 2013 - 2024 (USD Million)
      • 7.5.5.3. Market size, by treatment, 2013 - 2024 (USD Million)
    • 7.5.6. Mexico
      • 7.5.6.1. Market size, by type, 2013 - 2024 (USD Million)
      • 7.5.6.2. Market size, by diagnostics, 2013 - 2024 (USD Million)
      • 7.5.6.3. Market size, by treatment, 2013 - 2024 (USD Million)
    • 7.5.7. Argentina
      • 7.5.7.1. Market size, by type, 2013 - 2024 (USD Million)
      • 7.5.7.2. Market size, by diagnostics, 2013 - 2024 (USD Million)
      • 7.5.7.3. Market size, by treatment, 2013 - 2024 (USD Million)
  • 7.6. MEA
    • 7.6.1. Market size, by country, 2013 - 2024 (USD Million)
    • 7.6.2. Market size, by product, 2013 - 2024 (USD Million)
    • 7.6.3. Market size, by technology, 2013 - 2024 (USD Million)
    • 7.6.4. Market size, by end-use, 2013 - 2024 (USD Million)
    • 7.6.5. South Africa
      • 7.6.5.1. Market size, by type, 2013 - 2024 (USD Million)
      • 7.6.5.2. Market size, by diagnostics, 2013 - 2024 (USD Million)
      • 7.6.5.3. Market size, by treatment, 2013 - 2024 (USD Million)
    • 7.6.6. Saudi Arabia
      • 7.6.6.1. Market size, by type, 2013 - 2024 (USD Million)
      • 7.6.6.2. Market size, by diagnostics, 2013 - 2024 (USD Million)
      • 7.6.6.3. Market size, by treatment, 2013 - 2024 (USD Million)
    • 7.6.7. UAE
      • 7.6.7.1. Market size, by type, 2013 - 2024 (USD Million)
      • 7.6.7.2. Market size, by diagnostics, 2013 - 2024 (USD Million)
      • 7.6.7.3. Market size, by treatment, 2013 - 2024 (USD Million)

Chapter 8. Company Profiles

  • 8.1. Allengers Medical Systems Ltd
    • 8.1.1. Business overview
    • 8.1.2. Financial data
    • 8.1.3. Product landscape
    • 8.1.4. Strategic outlook
    • 8.1.5. SWOT analysis
  • 8.2. Boston Scientific Corporation
    • 8.2.1. Business overview
    • 8.2.2. Financial data
    • 8.2.3. Product landscape
    • 8.2.4. Strategic outlook
    • 8.2.5. SWOT analysis
  • 8.3. Coloplast A/S
    • 8.3.1. Business overview
    • 8.3.2. Financial data
    • 8.3.3. Product landscape
    • 8.3.4. Strategic outlook
    • 8.3.5. SWOT analysis
  • 8.4. Cook Medical LLC
    • 8.4.1. Business overview
    • 8.4.2. Financial data
    • 8.4.3. Product landscape
    • 8.4.4. Strategic outlook
    • 8.4.5. SWOT analysis
  • 8.5. C. R. Bard, Inc
    • 8.5.1. Business overview
    • 8.5.2. Financial data
    • 8.5.3. Product landscape
    • 8.5.4. Strategic outlook
    • 8.5.5. SWOT analysis
  • 8.6. DirexGroup
    • 8.6.1. Business overview
    • 8.6.2. Financial data
    • 8.6.3. Product landscape
    • 8.6.4. Strategic outlook
    • 8.6.5. SWOT analysis
  • 8.7. Dornier MedTech
    • 8.7.1. Business overview
    • 8.7.2. Financial data
    • 8.7.3. Product landscape
    • 8.7.4. Strategic outlook
    • 8.7.5. SWOT analysis
  • 8.8. EDAP TMS S.A.
    • 8.8.1. Business overview
    • 8.8.2. Financial data
    • 8.8.3. Product landscape
    • 8.8.4. Strategic outlook
    • 8.8.5. SWOT analysis
  • 8.9. Elmed Medical Systems
    • 8.9.1. Business overview
    • 8.9.2. Financial data
    • 8.9.3. Product landscape
    • 8.9.4. Strategic outlook
    • 8.9.5. SWOT analysis
  • 8.10. Karl Storz GmbH
    • 8.10.1. Business overview
    • 8.10.2. Financial data
    • 8.10.3. Product landscape
    • 8.10.4. Strategic outlook
    • 8.10.5. SWOT analysis
  • 8.11. Medispec Ltd
    • 8.11.1. Business overview
    • 8.11.2. Financial data
    • 8.11.3. Product landscape
    • 8.11.4. Strategic outlook
    • 8.11.5. SWOT analysis
  • 8.12. Olympus Corporation
    • 8.12.1. Business overview
    • 8.12.2. Financial data
    • 8.12.3. Product landscape
    • 8.12.4. Strategic outlook
    • 8.12.5. SWOT analysis
  • 8.13. Richard Wolf GmbH
    • 8.13.1. Business overview
    • 8.13.2. Financial data
    • 8.13.3. Product landscape
    • 8.13.4. Strategic outlook
    • 8.13.5. SWOT analysis
  • 8.14. Siemens Healthineers
    • 8.14.1. Business overview
    • 8.14.2. Financial data
    • 8.14.3. Product landscape
    • 8.14.4. Strategic outlook
    • 8.14.5. SWOT analysis
Back to Top
전화 문의
F A Q